Live from the NIH registry
Studies recruiting near Santa Cruz right now
Top 25 of 164 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Salinas Valley Memorial — Salinas, California (29.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente - Santa Clara ( Site 0082) — Santa Clara, California (26.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Palo Alto Medical Foundation-Sunnyvale — Sunnyvale, California (26.9 mi)
· Sponsor: NRG Oncology
Quadriceps Strengthening ACL Reconstruction
ACL Tear
N/A
Interventional 20 participants sought
Stanford Medicine Children's Health — Sunnyvale, California (26.9 mi)
· Sponsor: Stanford University
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sutter Palo Alto Medical Foundation: Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: American Society of Clinical Oncology
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Lumos Clinical Research Center — San Jose, California (26.1 mi)
· Sponsor: Syndeio Biosciences, Inc
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Retinal Diagnostic Center — Campbell, California (21.8 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Contraception
Phase 4
Interventional 1,404 participants sought
Planned Parenthood Mar Monte — San Jose, California (26.1 mi)
· Sponsor: University of Utah
A Study of NTX-1472 in Social Anxiety Disorder
Social Anxiety Disorder (SAD)
Phase 2
Interventional 100 participants sought
SOAR Clinical Study Site — San Jose, California (26.1 mi)
· Sponsor: Newleos Therapeutics, Inc.
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma
Phase 2
Interventional 146 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Major Depressive Disorder, Obsessive-Compulsive Disorder
Phase 2
Interventional 180 participants sought
Acacia Clinics — Sunnyvale, California (26.9 mi)
· Sponsor: Brigham and Women's Hospital
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12064 — San Jose, California (26.1 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Santa Clara, California (26.3 mi)
· Sponsor: Summit Therapeutics
Telenutrition for Individuals With SCI
Spinal Cord Injuries, Obesity
N/A
Interventional 96 participants sought
Santa Clara Valley Medical Center — San Jose, California (26.1 mi)
· Sponsor: Santa Clara Valley Health & Hospital System
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: NRG Oncology
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
End of Life, Cancer
N/A
Interventional 2,996 participants sought
Santa Clara Valley Medical Center — Fruitdale, California (23.6 mi)
· Sponsor: Stanford University
Toddlers' Responses to Strangers
Social Behavior
N/A
Observational 100 participants sought
Social Science 2 Building — Santa Cruz, California (0.4 mi)
· Sponsor: University of California Santa Cruz
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Immunoglobulin G4 Related Disease
Phase 3
Interventional 124 participants sought
San Jose Clinical Trials- Site Number : 8400016 — San Jose, California (26.1 mi)
· Sponsor: Sanofi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
Central Coast Nephrology — Salinas, California (29.5 mi)
· Sponsor: Regeneron Pharmaceuticals
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Dominican Santa Cruz Hospital — Santa Cruz, California (0.4 mi)
· Sponsor: NRG Oncology
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Alpha-Thalassemia, Beta-Thalassemia
N/A
Observational 1,000 participants sought
xCures — Los Altos, California (28.4 mi)
· Sponsor: xCures
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: SWOG Cancer Research Network
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
N/A
Observational 130 participants sought
Pacific Cancer Care — Monterey, California (27.3 mi)
· Sponsor: N-Power Medicine